Neurology & Pain Pharmacotherapy Review (copy)

0.0(0)
studied byStudied by 0 people
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/84

flashcard set

Earn XP

Description and Tags

These question-and-answer flashcards cover key concepts, drug details, mechanisms, risk factors, clinical features, and treatment principles for Parkinson’s disease, Alzheimer’s disease, epilepsy, and pain management based on the provided lecture notes.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

85 Terms

1
New cards

What neuronal pathway degenerates in Parkinson’s disease (PD)?

Dopaminergic neurons projecting from the substantia nigra pars compacta to the striatum (caudate nucleus + putamen).

2
New cards

List two broad etiologic categories for PD.

Environmental factors and genetic factors.

3
New cards

Name two major risk factors for developing PD.

Increasing age and male sex (men > women).

4
New cards

What four hallmark motor features characterize PD?

Bradykinesia, resting tremor, rigidity, and postural instability.

5
New cards

Give three non-motor symptoms often seen in PD.

Mental status changes, sleep disturbances, autonomic or sensory symptoms (e.g., constipation, orthostatic hypotension).

6
New cards

What lifestyle interventions are recommended for all PD patients?

Regular exercise, yoga/tai chi/dance, physiotherapy, and Lee-Silverman Voice Treatment/BIG therapy.

7
New cards

Describe the basic principle of deep-brain stimulation (DBS) for PD.

A battery-powered neurostimulator implanted subcutaneously below the clavicle delivers continuous electrical impulses to targeted brain structures to reduce motor symptoms.

8
New cards

Which PD surgical option is non-invasive and MRI-guided?

Focused ultrasound (unilateral).

9
New cards

Give two anticholinergic drugs used in PD.

Benztropine (Cogentin) and trihexyphenidyl (Artane).

10
New cards

Why do anticholinergics help tremor in PD?

Loss of dopamine increases striatal cholinergic activity, so blocking ACh can lessen tremor.

11
New cards

List two classic anticholinergic adverse effects.

Dry mouth and confusion (others: dry eyes, constipation, urinary retention, drowsiness).

12
New cards

State the suggested mechanisms of amantadine in PD.

Enhances presynaptic dopamine release and blocks glutamatergic NMDA receptors.

13
New cards

When is amantadine most commonly used in PD?

As adjunct to manage L-dopa-induced dyskinesia during “off” episodes.

14
New cards

Name one distinctive amantadine adverse effect visible on the skin.

Livedo reticularis (mottling).

15
New cards

Which controlled-release levodopa product may be split at the score mark?

Carbidopa/L-dopa CR (Sinemet CR).

16
New cards

What counseling point applies to Rytary capsules?

They may be opened and the beads sprinkled on food.

17
New cards

Give two common adverse effects of levodopa therapy.

Dyskinesias/motor fluctuations and orthostatic hypotension (others: nausea, impulse-control disorders, sleepiness, psychosis).

18
New cards

What is the only FDA-approved adenosine A2A receptor antagonist for PD?

Istradefylline.

19
New cards

Explain istradefylline’s pharmacologic action.

Blocks adenosine A2A receptors in the indirect movement pathway, reducing inhibitory output and improving movement.

20
New cards

Which cytochrome P450 enzymes metabolize istradefylline?

CYP1A1 and CYP3A4 (avoid strong inhibitors or adjust).

21
New cards

Name two irreversible MAO-B inhibitors used in PD.

Rasagiline (Azilect) and selegiline (Eldepryl, Zelapar).

22
New cards

Which MAO-B inhibitor is reversible and only approved as add-on to C/L?

Safinamide (Xadago).

23
New cards

Why must tolcapone use include liver monitoring?

Risk of fatal hepatotoxicity.

24
New cards

What color change can occur in urine with COMT inhibitors?

Brownish-orange discoloration.

25
New cards

Differentiate ergot- and non-ergot-derived dopamine agonists with one example each.

Ergot: bromocriptine; Non-ergot: pramipexole, ropinirole, rotigotine, apomorphine.

26
New cards

List two contraindications/cautions for dopamine agonists.

Avoid in dementia or significant cognitive impairment; use cautiously in older adults due to intolerance of side effects.

27
New cards

Which apolipoprotein allele is most strongly linked to Alzheimer’s disease (AD) risk?

APOE*4.

28
New cards

Name two genes other than APOE implicated in late-onset AD risk.

ABCA7 and TREM2 (also CLU, PICALM).

29
New cards

Which rare APP mutation is protective for AD?

A673T mutation in APP.

30
New cards

Give three environmental risk factors for AD.

Advanced age, low educational/brain reserve, vascular risks like hypertension, diabetes, hypercholesterolemia (others: head injury, depression, Down syndrome).

31
New cards

Summarize the amyloid cascade hypothesis.

Imbalance between production and clearance of β-amyloid leads to aggregation, plaque formation, and neuronal dysfunction driving AD.

32
New cards

What proteins form neurofibrillary tangles (NFTs) in AD?

Hyperphosphorylated tau proteins.

33
New cards

Which neurotransmitter deficit forms the basis for current AD symptomatic therapy?

Cholinergic deficiency (loss of acetylcholine activity).

34
New cards

State the primary treatment goal in AD.

Symptomatic treatment of cognitive deficits to preserve function as long as possible.

35
New cards

List the three cholinesterase inhibitors used for mild-to-moderate AD.

Donepezil, rivastigmine, and galantamine.

36
New cards

What NMDA receptor antagonist is used in moderate-to-severe AD?

Memantine (Namenda).

37
New cards

Give two key non-pharmacologic strategies in AD care.

Structured, consistent environment with orientation cues; avoid confrontation and validate patient feelings (others: adjust environment, monitor vascular health).

38
New cards

Define epilepsy according to ILAE.

At least two unprovoked seizures >24 h apart, OR one unprovoked seizure with ≥60 % 10-year recurrence risk, OR diagnosis of an epilepsy syndrome.

39
New cards

Name four common drugs that lower seizure threshold.

Imipenem (carbapenems), lithium, meperidine, bupropion (others: penicillin, quinolones, theophylline, clozapine, tramadol).

40
New cards

List three common seizure triggers.

Sleep deprivation, flashing lights (photostimulation), emotional or physical stress (others: hyperventilation, hormonal changes, drugs).

41
New cards

Describe the basic pathophysiology of a seizure.

Focal group of neurons becomes hyperexcitable and hypersynchronous, overwhelming normal inhibitory/excitatory balance.

42
New cards

Differentiate focal vs generalized seizure onset.

Focal: starts in one hemisphere; Generalized: starts simultaneously in bilaterally distributed networks.

43
New cards

Why is awareness assessment important in seizure classification?

Level of awareness affects patient safety and helps classify focal aware vs impaired-awareness seizures.

44
New cards

State the overarching treatment goals for epilepsy.

Achieve lifelong seizure freedom when possible with minimal adverse effects and optimal quality of life, preferably using monotherapy.

45
New cards

When should antiepileptic drug (AED) therapy be started?

Generally after ≥2 unprovoked seizures; after a single seizure based on clinical judgment of recurrence risk.

46
New cards

Give the five broad mechanisms of AED action.

1) Voltage-gated Na⁺ or Ca²⁺ channel inhibition, 2) enhancement of GABAergic inhibition, 3) suppression of glutamatergic excitation, 4) modulation of neurotransmitter release, 5) unique/unknown mechanisms.

47
New cards

List two shared adverse-effect categories of most AEDs.

CNS effects (dizziness, sedation) and risk of suicidal ideation.

48
New cards

Which HLA allele is linked to severe cutaneous reactions with aromatic anticonvulsants?

HLA-B*1502.

49
New cards

Provide two key counseling points for patients starting AEDs.

Do not abruptly discontinue medication; report any mood changes or suicidal thoughts promptly (others: avoid St. John’s Wort, caution with generics).

50
New cards

Name four inflammatory mediators involved in pain signal initiation.

Prostaglandins, bradykinin, histamine, and substance P (others: cytokines, serotonin).

51
New cards

Give two major consequences of inadequately treated pain.

Reduced quality of life/limited ADLs and increased healthcare utilization/costs (others: physiologic stress).

52
New cards

Identify three barriers patients face in pain management.

Reluctance to report pain, fear of addiction/adverse effects, financial constraints (others: communication issues).

53
New cards

Define nociceptive pain.

Pain from actual or potential tissue injury caused by activation of nociceptors; typically sharp, dull, or aching and localized.

54
New cards

What acronym helps systematically assess pain characteristics?

PQRST – Palliative/provocative, Quality, Radiation, Severity, Temporal factors.

55
New cards

Explain acetaminophen’s primary mechanism.

Central inhibition of prostaglandin synthesis (analgesic and antipyretic, minimal anti-inflammatory effect).

56
New cards

State the boxed warning for acetaminophen.

Severe liver injury leading to acute hepatic failure—dose-dependent hepatotoxicity.

57
New cards

How do NSAIDs produce analgesia?

Reversibly inhibit cyclo-oxygenase (COX-1 and COX-2), reducing prostaglandin synthesis → analgesic, antipyretic, and anti-inflammatory effects.

58
New cards

List two common NSAID adverse effects.

GI irritation/ulceration and renal impairment (others: inhibited platelet aggregation, bronchospasm).

59
New cards

Name three central nervous system effects of opioids.

Analgesia, sedation/mental clouding, and miosis (others: euphoria, nausea, respiratory depression).

60
New cards

What is the primary life-threatening adverse effect of opioids?

Respiratory depression.

61
New cards

Differentiate opioid tolerance from dependence in one sentence.

Tolerance is decreased drug effect requiring higher doses, whereas dependence is physiologic adaptation causing withdrawal symptoms upon cessation.

62
New cards

Define opioid addiction.

A chronic relapsing disease characterized by compulsive drug seeking and use despite harmful consequences.

63
New cards

Give an example of a pure opioid agonist and a mixed agonist-antagonist.

Pure agonist: morphine; Mixed agonist-antagonist: buprenorphine or nalbuphine.

64
New cards

List three non-pharmacologic modalities for acute musculoskeletal pain.

Ice, heat, rest/elevation/immobilization, and exercise/physical therapy (any three).

65
New cards

Identify two routes other than oral for delivering analgesics.

Intravenous (IV) and transdermal (others: rectal, subcutaneous, intrathecal).

66
New cards

What is naloxone and how is it supplied for layperson use?

A pure opioid antagonist that rapidly reverses opioid overdose; available as nasal spray or intramuscular autoinjector.

67
New cards

How soon may naloxone be re-administered if the patient does not respond?

Every 2-3 minutes until medical help arrives.

68
New cards

Describe ‘focused ultrasound’ in PD treatment in one phrase.

MRI-guided, non-invasive ultrasonic ablation of unilateral tremor target.

69
New cards

Which MAO-B inhibitor’s ODT formulation minimizes first-pass metabolism?

Selegiline ODT (Zelapar).

70
New cards

What serious psychiatric adverse effect can levodopa therapy provoke?

Impulse-control disorders (e.g., pathological gambling, shopping).

71
New cards

Why should ergot-derived dopamine agonists be used cautiously?

Risk of fibrotic complications (e.g., cardiac valvulopathy, pulmonary fibrosis).

72
New cards

Name two neurotransmitters implicated in AD besides acetylcholine.

Glutamate and serotonin.

73
New cards

What non-ergot dopamine agonist is available as a transdermal patch?

Rotigotine.

74
New cards

Which COMT inhibitor offers once-daily dosing?

Opicapone (Ongentys).

75
New cards

List the two primary goals when treating AD.

1) Preserve cognitive function and daily activities; 2) Manage behavioral and psychiatric symptoms.

76
New cards

State one benefit of combining donepezil with memantine.

Addresses both cholinergic deficit and glutamatergic excitotoxicity for moderate-to-severe AD.

77
New cards

Which diet can reduce seizure frequency in refractory epilepsy?

Ketogenic diet.

78
New cards

What device delivers periodic electrical impulses to reduce seizures?

Vagus nerve stimulator (VNS).

79
New cards

Give two common motor descriptors used in seizure classification.

Clonic (rhythmic jerking) and tonic (rigid/tense muscles) movements.

80
New cards

Name the screening allele for carbamazepine-induced Stevens-Johnson syndrome in Asian ancestry.

HLA-B*1502.

81
New cards

Which endogenous opioids act on mu receptors?

Endorphins (particularly β-endorphin).

82
New cards

Explain why mixed agonist-antagonist opioids can precipitate withdrawal.

They inactivate mu receptors in patients physically dependent on full agonists, abruptly lowering receptor activation.

83
New cards

What is the recommended approach to discontinuing long-term AED therapy?

Gradual taper over weeks to months to prevent withdrawal seizures.

84
New cards

Which inflammatory hypothesis factor involves free radicals in AD?

Oxidative stress.

85
New cards

Identify two patient factors increasing risk for opioid misuse.

Personal or family history of addiction and untreated mental health disorders (others: early substance use, poor coping skills).